Company intelligence / Profile preview

BetterLife Pharma Inc.

Vancouver, British Columbia, Canadaabetterlifepharma.com ↗
Ownership
Private
Development stage
Other
01

Overview

BetterLife is currently conducting IND-enabling studies for its lead compounds. The cardio-pulmonary GLP studies for BETR-001 have been completed, and metabolism and genotoxicity GLP studies are to be initiated soon[5].

Therapeutic areas
PsychiatryNeurology
Modalities
Small moleculesNon-hallucinogenic psychedelic compounds
Industry
Biotech
02

Drug pipeline

5 assets

AP-002

2

4 more assets in the full pipeline.

03

Partnerships

Strategic relationships across Canada, United States and Switzerland[3]

Beyond the preview

Go deeper on BetterLife Pharma Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BetterLife Pharma Inc..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call